Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer
Author:
Zhang Ling-li1, Zhang Lian-feng1, Shi Yun-bo2
Affiliation:
1. Department of Gastroenterology , The First Affiliated Hospital of Zhengzhou University , Zhengzhou 450052, Henan , China 2. Department of Neurology , The First Affiliated Hospital of Zhengzhou University , No. 1 Jianshe East Road , Zhengzhou 450052, Henan , China
Abstract
Abstract
The paxillin and M2 macrophage are all involved in cell proliferation and tumor progression, and this study aims to explore the interaction between them in colon cancer and the role of paxillin in cancer progression. Expression of mRNAs and proteins was determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot, separately. Endogenous expression of genes was modulated by recombinant plasmids and cell transfection. The levels of cytokines were determined by enzyme-linked immunosorbent assay (ELISA). The cell viability, invasion and migration were detected using the MTT assay, the transwell assay and the wound-healing cell migration assay, respectively. A nude mouse model for human colon cancer was constructed for tumor orthotopic expression. Paxillin was up-regulated in tumor-associated macrophages (TAMs). Paxillin was up-regulated in process of M2 macrophage polarization. M2 macrophage polarization was inhibited with paxillin suppressed. Down-regulated paxillin inhibited cell proliferation and invasion in colon cancer through suppressing M2 macrophage polarization. PI3k/Akt inhibitor repressed M2 macrophage polarization through down-regulating paxillin. PI3k/Akt inhibitor inhibited the function of the macrophage in promoting cell proliferation and invasion of colon cancer through down-regulating paxillin. Down-regulated paxillin in macrophages inhibited tumor growth of colon cancer. With the PI3K/AKT pathway inhibited, down-regulated paxillin suppressed colon cancer cell proliferation and invasion by inhibiting the M2 macrophage polarization, thereby restraining the tumor progression.
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference29 articles.
1. Abshire, M.Y., Thomas, K.S., Owen, K.A., and Bouton, A.H. (2011). Macrophage motility requires distinct α5β1/FAK and α4β1/paxillin signaling events. J. Leukoc. Biol. 89, 251–257. 2. Ameka, M., Kahle, M.P., Perez-Neut, M., Gentile, S., Mirza, A.A., and Cuevas, B.D. (2014). MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells. Biochem. J. 464, 99–108. 3. Birt, D.F. and Phillips, G.J. (2014). Diet, genes, and microbes: complexities of colon cancer prevention. Toxicol. Pathol. 42, 182–188. 4. Chen, Y., Wang, S.X., Mu, R., Luo, X., Liu, Z.S., Liang, B., Zhuo, H.L., Hao, X.P., Wang, Q., Fang, D.F., et al. (2014). Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer. Cell Rep. 7, 1982–1993. 5. Deakin, N.O. and Turner, C.E. (2008). Paxillin comes of age. J. Cell Sci. 121, 2435–2444.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|